Sage Financial Management Group’s Pfizer PFE Stock Holding History

Sage Financial Management Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-314	Closed	-$11K	–	89
2021 Q1	$11K	Buy	+314	New	+$11.1K	0.01%	97

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sage Financial Management Group's PFE Position: Q2 2021 in Review

Sage Financial Management Group sold out of Pfizer (PFE) in Q2 2021, closing a stake of 314 shares — an estimated $11K sold.

Sage Financial Management Group first reported a position in PFE in Q1 2021 and held it in 1 quarter. The position peaked at $11K in Q1 2021. 2,733 funds tracked by Wall St. Rank hold PFE as of Q2 2021.

Sage Financial Management Group reported no remaining Pfizer position as of Q2 2021 after selling out during the quarter.
Sage Financial Management Group sold 314 Pfizer shares in Q2 2021, an estimated $11K.
Sage Financial Management Group first reported a position in Pfizer in Q1 2021 and held it in 1 quarter.
Sage Financial Management Group's Pfizer position peaked at $11K in Q1 2021.
2,733 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.

Based on Sage Financial Management Group's 13F filing for Q2 2021, filed 3 Aug 2021.